Corvista Health’s point-of-care device, used to predict pulmonary hypertension (PH), also appears to work well at identifying heart failure.

The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...